Adcentrx Therapeutics to Present Preclinical Data for Nectin-4 ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024

/PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other...

Related Keywords

United States ,San Diego ,California ,American , ,American Association For Cancer Research ,Antibody Drug Conjugate ,American Association ,Cancer Research ,Annual Meeting ,Antibody Drug Conjugates ,Adcentrx Therapeutics ,